For example, cyclin D1-negative MCLs[10] can overexpress cyclin D2 or cyclin D3,[11] and aggressive MCLs must be distinguished from cyclin D1-positive diffuse large B cells.[12] In such cases, SOX11 has emerged as a potential novel diagnostic marker of MCL.[6, 13]. This evidence concerns the gene SOX11 and mantle cell lymphoma.